|
|
|||||||||||||||||||||||
Article Navigation
|
The Risk of recurrence in prostate cancerby: Fritz Frei Prostate cancer disease Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high. Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease. 1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent. 2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary. 3. The Decisions about the best management of prostate cancer can be very complex and depend upon the: - Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly) - The impact that treatment can have on quality of life, including sexual activity - Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory) - Age and general health of the patients at diagnosis - Patient’s preference for treatment - PSA at diagnosis 4. The treatment options for prostate cancer are: - Deferred treatment often called ‘watchful waiting’ or 'active surveillance' - Surgery – Radical Prostatectomy - Radiotherapy – External Beam and/or Brachytherapy -Hormonal (endocrine) therapy – Androgen Ablation e.g. anti-androgens, medical castration (LHRHa) or surgical castration - Chemotherapy - Palliative Therapy e.g. chemotherapy - Investigational Therapies Prostate Cancer Recurrence Rates *** Prostate cancer is now detected at earlier stages due to heightened awareness and improved screening techniques. Despite definitive therapy, cancer cells may remain and can go undetected for years until they develop into metastatic disease. The risk of recurrence is high, suggesting there is a need to improve treatment approaches. Therefore, it is important to predict pathological stage and risk of disease recurrence early, so that appropriate treatment and/or monitoring can be initiated. The result's of all new treatments will bring us in the future the chance of a lower prostate recurrance. **You can inform you about the recurrence Rates on: http://www.prostateline.com/prostatelinehcp/9898_15850_8_0_0.aspx This gives you an overview with a study case – and the results. Health-Service-Online Admin Fritz http://www.cancer-info.info Latest Cancer News:Tackling Cancer: Leukemia's Biggest Current and Upcoming Players Cancer research is big business, and it pays to know where research dollars are headed. University of Washington Receives CEO Cancer Gold Standard Accreditation UW Medicine, a leading healthcare provider serving Seattle and the Northwest, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior. GE Healthcare Launches #GetFit Cancer Prevention Campaign GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year?s campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement. Breast cancer: What is the risk? How high is the risk for the average woman? PCF China Announces Two New Young Investigators for Advancing Prostate Cancer Research The Prostate Cancer Foundation today announced that it is funding two more Young Investigators in China to lead innovative research projects within the country and expand PCF?s global knowledge exchange on game-changing research in prostate cancer. Sukamto Sia Announces Ten Years of Volunteer Work With American Cancer Society NEW YORK, May 20, 2013 /PRNewswire-iReach/ -- Sukamto Sia is proud to announce ten years of involvement with the American Cancer Society. Sukamto Sia enjoys volunteering his time to the American Cancer ... Cancer care biggest winner in budget Cancer care has been the biggest winner in health from the budget, but smokers will have to pay more. Breast Cancer: How We'll Better Predict Who it Strikes (Op-Ed) Annette Lee, associate investigator at the Feinstein Institute for Medical Research, contributed this article to LiveScience's Expert Voices: Op-Ed & Insights. We may never be able to fully prevent the occurrence of breast cancer, but I believe within five years we will be able to identify individuals who will develop breast cancer with much higher accuracy than we can with the predictive tools ... Cancer Patients May Face Higher Bankruptcy Odds Title: Cancer Patients May Face Higher Bankruptcy Odds Category: Health News Created: 5/15/2013 4:35:00 PM Last Editorial Review: 5/16/2013 12:00:00 AM Facing Jolie's cancer dilemma Actress Angelina Jolie?s revelation this week that she?d had both breasts removed to lower her elevated risk of cancer came as a bombshell to many -- but not to three sisters from Berkeley Heights, N.J. MGH, AstraZeneca partner to create new drug combos - Boston Globe
|
||||||||||||||||||||||
Copyright © 2006 CancerAdvice.org